Work

Synergistic combinations of signaling pathway inhibitors: Mechanisms for improved cancer therapy

Year: 2009

Type: article

Source: Drug Resistance Updates

DOI: 10.1016/j.drup.2009.03.001

Authors: Paul Dent, David T. Curiel, Paul B. Fisher, Steven Grant

Institutions: Virginia Commonwealth University, VCU Massey Comprehensive Cancer Center, University of Alabama at Birmingham

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Samuel Waxman Cancer Research Foundation, National Foundation for Cancer Research, Universal, National Institutes of Health, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke

Awards: G240198448, G2447325627, G2809070691, G3231619352, Signaling Pathways Regulating Epithelial Cell Survival, Translational Applications of mda-7/IL-24 in Cancer, G4677677456, G526054707, G6425088875, G6450645852, G837484194, MDA-7: Novel Cancer Therapeutic Gene, Role of TRRAP in the p53-Mediated Transcription of mdm2

OpenAlex ID: W1965136295

FWCI: 2.999

Cites: 124

Cited by: 59

Related to: 10